The pteridine neopterin (NP) was shown to be produced by monocytes and has been known as a userul maker of immunological activation, although, the biological activity of this agent is still unclear. To <.'!ucidate the biological function of NP, the changes in the number of blood leukocyte, bone marrow ,md spleen hemopoietic progenitor cells after intraperitoneal administration of NP into mice were in-\· cstigated. Administration of NP increased the number of blood leukocytes about 2 fold higher than that of the control at days 7 and 14. Blood films, made by smearing samples of peripheral blood, showed the increment of granulocytes in blood of NP treated animals. The number of granulocyte-ma--:rophage progenitor cells (CFU-GM) was also increased in both bone marrow and spleen in mice with ~p administration . Extensive study showed that NP stimulated the hematological recovery in bone marrow transplanted animals . All these findings suggest that NP has a stimulating activity on hemopoiesis by afiecting the proliferation and differentiation of hemopoietic progenitor cells in vivo.
Introduction
The neopterin (NP) is a metabolite of guanosine triphosphate in the synthetic pathway of biopterin (1) . NP is produced in large amounts by monocytes/macrophages upon stimulation with interferon-y (IFN-y) (2) . Immune responses in vivo and in vitro are accompanied by increased neopterin levels and considerable interest has cen- § Author to whom correspondence should be addressed.
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tered on the measurement of neopterin as a marker of immunological activation (2) (3) (4) . It is suggested that the NP and NP derivatives may modulate the redox balance in biological systems, however, the biological activity of NP is little known. Schobersberger et al. reported that the NP induced apoptosis in the rat alveolar epithelial cell line L2 (5) . NP is also found to inhibit erythropoietin gene expression (6) and to induce proto-oncogene c-fos expression in vitro (7) .
The aim of this study was to test whether exogenously administrated NP affects the hematopoiesis in vivo. Groups of mice were injected intraperitoneally with NP, then the changes in the number of peripheral blood cells as well as hemopoietic progenitors in bone marrow and spleen were investigated. Furthermore, NP was also administrated in bone marrow transplanted mice, and the effects of NP during the period of hematological regeneration from marrow transplantation was studied.
Materials and Methods

Mice
Male C 3 H / HeN mice, 8-10 weeks old, were obtained from Charles River Japan Inc . (Yokohama, Japan) and kept under specific pathogenfree conditions .
Irradiation
The mice were irradiated with X-rays operating at 180 kVp-20 mA and a rate of 0.5 Gy/min through a 1.0 mm Al+0 .5 mm eu filter.
Neopterin
D-( + )-Neoptcrin was obtained from SIGMA (St . Louis, MO ). NP was dissolved in IN HCI at a concentration of 1 mg/ ml, diluted t~n times with Dulbecco's phosphate-buffered saline ( PBS) supplemented with 10% fetal calf serum (FCS).
Preparation of bone marrow and spleen cells
Bone marrow cells were obtained from femura and tibiae aseptically by flushing with alpha-Minimum Essential Medium (a-MEM) into 15 ml plastic tubes using a 2 I -gauge needle and a 1 ml syringe, and clumps of cells were dispersed by repeated passage through a 21-gauge needle . Spleens were minced in ice-cold a-MEM, gently homogenized in a Potter's glass homogenizer and a single cell suspension was made in a similar way to bone marrow cells. Aliquots of bone marrow and spleen cells were diluted in Turk's solution and nucleated cells were counted. Viability of the cells thus obtained was between 95-98% as measured by the Trypan blue exclusion method.
Administration of NP
Various concentrations of NP were injected intraperitoneally for 3 days, then the number of peripheral leukocytes, CFU-GM in bone marrow . md spleen were counted at days 1, 7 and 14. At 
Transplantation
Mice were subjected to 9.5 Gy whole-body irradiation. One X 10 6 of bone marrow cells in 0.25 ml a-MEM obtained from syngenic mice were transplanted via tail veins 24 h after irradiation. Various concentrations of NP were administrated intraperitoneally for 3 consecutive days after marrow transplantation. Changes in the number of peritoneal leukocytes, CFU -GM in bone marrow during the period of hematological regeneration from marrow transplantation was studied at days 3, 7 and 14 after transplantation .
Assays for CFU-GM
Bone marrow and spleen cells from animals were suspended in a-MEM, counted, washed once and resuspended in a-MEM. For the CFU-GM assay, cells were incubated in 0.3% semisolid agar in a-MEM containing 10% (vol/vol) FCS and 20% (vol/vol) mouse peritoneal macrophageconditioned medium as a source of colony-stimulation activity (8) . Cultures were maintained for 7 days at 37"C in 5% CO 2 in humidified air and then examined by phase contrast microscopy. Colonies containing more than 50 cells were considered to be CFU-GM and counted.
Hematological investigation
Peripheral blood was obtained from anesthetized mice via the retro-orbital plexus and analyzed using an electronic counter (Erma Optical works, Tokyo ). The mice were not bled repeatedly. Differential cell counts were performed after staining the blood smears with May-Giemsa.
Statistical analysis
At least 5 animals per group were examined. All the experiments were performed in triplicate . The means and standard deviations were calculated and analyzed by Student's t-test. Differences at p <0 .05 were considered significant.
Results
Effects of intraperitoneal administrated NP on hemopoiesis in vivo
Mice were injected intraperitoneally with 10 '; :1d 100 ~g/mouse of NP for 3 days and the -_l mber of peripheral leukocytes and CFU-GM in bone marrow and spleen were counted after 1, 7 and 14 days. A group of mice were injected with PBS supplemented with 10% FCS, as controls. The results were expressed as a percentage of the control. Figure 1 shows that the treatment with ~P increased the number of peripheral leukocytes :lbout two fold higher than that of the controls at days 7 and 14 (absolute number of leukocytes in control animals were 5900± IOOO,8200± 1500 :lnd 6600±950 at days I, 7 and 14, respectively). Differential cell counts were performed at day 7 and the increased number of granulocytes were observed from 39.8% (control) to 49.2% and 46. 0% in 100 and 10 ~g/mouse of NP administrated animals, respectively ( Figure 2 ). Increased number of CFU-GM in bone marrow by treatment with NP was observed ( Figure 3 ) (absolute number of CFU -GM per tibia in control animals were 30744± 3118, 38305± 1732 and 32286± 3371 at days 1, 7 and 14, respectively). Figure 4 shows that the number of CFU -GM in the spleen was also increased after NP administration, but decreased gradually at days 7 and 14 (absolute number of CFU-GM per spleen in control animals were 14361±260I, 15050± 1194 and 14345± 1367 at days 1, 7 and 14, respectively). The recovery of peripheral leukocytes in bone marrow-transplanted mice with and without NP treatment was examined ( Figure 5 ). The number of leukocytes declined after transplantation in both NP-treated and non-treated animals transplanted with 1 x 10 6 cells. Two weeks after transplantation, considerably more leukocytes were observed in mice treated with both 100 and 1 0 ~g NP than those transplanted without NP treatment.
Effects of NP on hemopoiesis in animals during the period of hematological regeneration from marrow transplantation
Bone marrow cells from transplanted mice with and without NP were analyzed for in vitro progenitor cell contents 3, 7 and 14 days after transplantation. Figure 6 shows that NP treatment significantly increased the numbers of CFU -GM in 4000 .. 
Discussion
The NP is known to be produced in excess by monocytes/ macrophages upon stimulation with IFN-y (2 ). The diagnostic value of NP has been established in autoimmune diseases, rejection of transplanted organs, malignant diseases, infectious diseases including AIDS or hepatitis (reviewed in 9 ) . While it was evident that stimulation of the cellular immune system leads to an increase of NP biosynthesis and relea~~, a possible biological function of NP remained elusive. It has been found that NP inhibit erythropoietin gene expression (6), induce proto-oncogene c-fos expression (7 ) and enhance cell damage caused by UV-A irradiation ( 10) . A recent report showed that when NP, was exogenously added to a cell culture it passed through the cell membrane and increased the intracellular calcium concentration in monocytic cells ( 11) . An increase of intracellular calcium has been shown to play an important role in the activation of monocytic cells, including the production of cytokines which may possess hematological activities (12) (13) (14) (15) .
The results of this study show that intraperitoneal administration of NP increased the number of peripheral leukocytes about two fold higher than that of controls 7 and 14 days after administration, but no significant increase was found one day after administration. In addition, increased number of CFU-GM in bone marrow and spleen was observed one day after NP administration, then CFU -GM was gradually decreased. These findings suggest that NP did not induce the migration of leukocytes from the marrow pool to the blood, but stimulated the proliferation and differentiation of progenitor cells in hemopoietic organs which resulted in the elevation of blood leukocytes . The action of NP for hematological activation was found in bone marrow transplanted recipients and quick recovery of peripheral leukocytes from the nadir was observed.
The mechanism(s ) responsible for the effect of NP on hemopoietic progenitors is/ are still unclear. Recently, we obtained evidence that NP did not have a direct action on hemopoietic progenit ors in vitro, but stimulative activity of NP on bone marrow stromal cells produced various cytokines (Aizawa et al., in preparation) . Bone marrow stromal cells are known as essential elements for supporting proliferation and differentiation of hemopoietic stem cells in vivo and in vitro (16) (17) (18) . It is interesting that lymphopoiesis is also regulated by stromal cells in vitro (19) (20) (21) (22) . Thus, the activation of stromal cell function by NP might be concerned with modulating either hematological or immunological reactions in vivo.
Further study is required to elucidate the mechanism(s) of action of NP, however, the present findings taken together indicate that NP has a stimulating activity f(x hematopoiesis in vivo and may provide a basis for the usefullness of NP in bone marrow transplantation recipients during the period of hematological regeneration by activation of proliferation and difterentiation of hemopoietic progenitor cells.
